"Driven by Rising Chronic Disease Burden and Breakthrough FDA Approvals, Biopharmaceutical Market Surges with Demand for Monoclonal Antibodies, Gene and Cell Therapies, and Innovative...
TORONTO, July 28, 2025 /PRNewswire/ -- Qynapse, a technology company using AI to enhance the quantification and predictive capabilities of imaging to improve outcomes for...
Groundbreaking Insights into Neurodegenerative Disease Biomarkers to be Unveiled through 30+ Posters and Presentations at International Meeting
FREMONT, Calif., July 28, 2025 /PRNewswire/ -- Alamar...
Discover the future of Cannabis-Induced Psychosis (CIP) with the latest Pipeline Insight 2025 report. Gain in-depth analysis of CIP therapeutic developments, from early to marketed stages, including collaboration trends, licensing deals, and clinical trials. Navigate key players, active projects, and market growth strategies within the evolving CIP landscape.
Discover the future of Cannabis-Induced Psychosis (CIP) with the latest Pipeline Insight 2025 report. Gain in-depth analysis of CIP therapeutic developments, from early to marketed stages, including collaboration trends, licensing deals, and clinical trials. Navigate key players, active projects, and market growth strategies within the evolving CIP landscape.
Sujata Setia, Mithail Afrige Chowdhury and Steve Gschmeissner awarded £10,000 each for images exploring domestic abuse, climate migration and the hidden dangers of cholesterol
Sujata Setia, Mithail Afrige Chowdhury and Steve Gschmeissner awarded £10,000 each for images exploring domestic abuse, climate migration and the hidden dangers of cholesterol
The U.S. cryoablation probes market, valued at USD 51.71 million in 2024, is expected to reach USD 133.16 million by 2033, growing at an 11.16% CAGR. Growth is driven by rising cases of cardiovascular diseases and cancer, advanced technologies, and increased demand for minimally invasive procedures.
The U.S. cryoablation probes market, valued at USD 51.71 million in 2024, is expected to reach USD 133.16 million by 2033, growing at an 11.16% CAGR. Growth is driven by rising cases of cardiovascular diseases and cancer, advanced technologies, and increased demand for minimally invasive procedures.
KUALA LUMPUR, Malaysia, July 25, 2025 /PRNewswire/ -- The Malaysia Healthcare Travel Council (MHTC) launched Malaysia Year of Medical Tourism (MYMT) 2026 today at the...
KUALA LUMPUR, Malaysia, July 25, 2025 /PRNewswire/ -- The Malaysia Healthcare Travel Council (MHTC) launched Malaysia Year of Medical Tourism (MYMT) 2026 today at the...
BEIJING, July 25, 2025 /PRNewswire/ -- The third China International Supply Chain Expo (CISCE) was held from July 16 through 20 in Beijing, providing...
BEIJING, July 25, 2025 /PRNewswire/ -- The third China International Supply Chain Expo (CISCE) was held from July 16 through 20 in Beijing, providing...